Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Food Challenge After Omalizumab for Food Allergy
NCT07845552Phase 4Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in food allergy, sponsored by Johns Hopkins University. Started Oct 2026; status: recruiting.
02
Drugs
omalizumab
03
Conditions
food allergy
Beyond the preview
Go deeper on NCT07845552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845552.